Davis, United States
Expression Systems, founded in 1995, is a leading company in Baculovirus (BEVS) mediated protein expression technology and insect cell culture within the Biotechnology industry. Based in the United States, the company specializes in providing insect and mammalian cell culture media, reagents, and contract services that support vector design & construction, virus production, and protein expression/purification.
As a notable player in the biotechnology sector, Expression Systems offers a comprehensive suite of products and services aimed at facilitating the protein expression process. Leveraging its expertise in Baculovirus and insect cell culture, the company has demonstrated a strong commitment to advancing bioprocessing capabilities and enabling efficient protein production.
While specific details regarding the latest investment and the involved investors are not disclosed, Expression Systems presents an intriguing opportunity for venture capital firms to potentially contribute to the advancement of innovative biotechnological solutions. With its established position and specialized focus, the company stands as a compelling prospect for investors seeking involvement in the biotechnology arena.
